ESR2 and breast carcinoma: Mishra et al. reported that the alteration in the expression of ER(α)/ER(β) balance is a critical step in breast cancer development and progression; the role of ER(β) in breast cancers expressing ER(β) alone, without ER(α), is less clear to date [56].